Quick answers
- What is Colchicine (colchiceine) used for?
- The FDA-approved label (Colchicine, A-S Medication Solutions, August 5, 2024) says: “Colchicine tablets are an alkaloid indicated for: Prophylaxis and treatment of gout flares in adults. Familial Mediterranean fever (FMF) in adults and children 4 years or older. 1.1 Gout Flares Colchicine tablets are indicated for prophylaxis and the treatment of acute gout flares. Prophylaxis of Gout Flares: Colchicine tablets are indicated for prophylaxis of gout flares. Treatment of Gout Flares …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Colchicine (colchiceine) have a boxed warning?
- No. None of the 4 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Colchicine (colchiceine)?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Colchicine (colchiceine) been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Colchicine (colchiceine)?
- 4 companies list prescription products of Colchicine (colchiceine) in the FDA NDC Directory, including Zydus Lifesciences Limited, Zydus Pharmaceuticals USA Inc. and NorthStar Rx LLC.
What Colchicine (colchiceine) is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Colchicine tablets are an alkaloid indicated for: Prophylaxis and treatment of gout flares in adults. Familial Mediterranean fever (FMF) in adults and children 4 years or older. 1.1 Gout Flares Colchicine tablets are indicated for prophylaxis and the treatment of acute gout flares. Prophylaxis of Gout Flares: Colchicine tablets are indicated for prophylaxis of gout flares. Treatment of Gout Flares …
— FDA label: Colchicine, A-S Medication Solutions, effective August 5, 2024. Read the full label on DailyMed →
The FDA has 4 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 4 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet |
|---|---|
| Route | Oral |
| Prescription products | 6 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| colchiceine 0.6 mg tablet | Generic | $0.1189 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Zydus Lifesciences Limited2 products
- Zydus Pharmaceuticals USA Inc.2 products
- NorthStar Rx LLC1 product
- A-S Medication Solutions1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (1)
- ANDA211519Zydus Pharms · February 19, 2019
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| SPL set ID of the quoted label | 7b6abc78-b2d6-4949-b109-4c857f37ef12 |
|---|---|
| FDA labels (SPL) | 4 |
| FDA applications | 1 ANDA |
| Active ingredients (FDA) | COLCHICEINE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Colchicine, A-S Medication Solutions, effective August 5, 2024; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →